The growing demand for controlled immunological research and therapeutic creation has spurred significant improvements in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression methods, including microbial hosts, higher cell cultures, and insect ex